导读： 2024年度，钢研纳克实现营业收入10.98亿元，同比增长15.60%；归属于上市公司股东的净利润1.45亿元，同比增长 15.37%，业绩保持稳健增长态势。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 钢研纳克检测技术股份有限公司（简称：钢研纳克）于近日发布2 0 2 4年度报告，交出了一份营收与净利润双双增长超 1 5%的亮眼成绩单。 2 0 2 4 年 ， 钢 研 纳 克 实 现 营 业 收 入 1 0 . 9 8 亿 元 ， 同 比 增 长 1 5 . 6 0%； 归 属 于 上 市 公 司 股 东 的 净 利 润 1 . 4 5 亿 元 ， 同 比 增 长 1 5 . 3 7%，业绩保持稳健增长态势。 截至2 0 2 4年底，钢研纳克总资产达2 0 . 9 4亿元，较上年增长11 . 4 6%。 钢研纳克以金属材料检测技术为核心，业务涵盖检测服务、检测分析仪器、标准物质/标准样品、能力验证服务、腐蚀 防护工程与产品，以及其他检测延伸服务。其服务和产品主要应用于钢铁、冶金、有色、机械、航空航天、高铁、核 电、汽车 ...

Core Viewpoint - The company Huace Testing announced a cash dividend plan for the fiscal year 2024, proposing a distribution of 1 yuan per share (before tax), totaling approximately 167 million yuan, which represents 18.16% of its net profit [2]. Group 1: Dividend Distribution - The proposed cash dividend for 2024 is 1 yuan per share, with a total cash payout of 167 million yuan [2]. - This marks the 17th cumulative cash distribution since the company's listing [2]. - The dividend yield for 2024 is 0.78%, an increase from 0.55% in 2023 [2]. Group 2: Financial Performance - For the fiscal year 2024, the company reported total revenue of 6.084 billion yuan, reflecting a year-on-year growth of 8.55% [2]. - The net profit for the same period was 921 million yuan, showing a year-on-year increase of 1.19% [2]. - The basic earnings per share (EPS) is reported at 0.55 yuan, with a weighted average return on equity (ROE) of 14.07% [2]. Group 3: Market Activity - The stock experienced a net outflow of 26.28 million yuan in principal funds today, with a total net outflow of 53.89 million yuan over the past five days [3]. - The latest margin financing balance for the stock is 564 million yuan, which has increased by 45.23 million yuan, representing an 8.72% rise over the past five days [4]. Group 4: Industry Comparison - Among the 22 companies in the social services sector that announced their 2024 dividend plans, Huace Testing's cash payout ranks fifth, with the highest being 548 million yuan from Foreign Service Holdings [4]. - The cash payout of Huace Testing accounts for 18.16% of its net profit, which is relatively moderate compared to other companies in the sector [4].

Group 1: Company Insights - BoShi Fund conducted research on six listed companies, focusing on their strategic initiatives and market performance [1][2][3][4][5][6] - Jerry Holdings is executing an international strategy with significant achievements in overseas markets, particularly in the Middle East, and plans to enhance cash flow management and cost reduction in 2024 [1] - Luxshare Precision has a limited impact from U.S. tariffs due to a small proportion of exports to the U.S., and it is observing the situation while emphasizing global capacity layout opportunities [2] - SuShi Testing anticipates a decline in main business revenue and net profit in 2024, with a focus on controlling capital expenditure in traditional areas while exploring emerging sectors [3] - Aerospace Rainbow has made significant progress in drone and missile businesses, with optimistic market expectations for exports and ongoing development of new products [4] - Crystal Optoelectronics is committed to a global and technology-driven strategy, with growth in AR and automotive sectors, while managing production adjustments and maintaining profitability [5] - Guanghe Technology is experiencing steady revenue growth driven by market opportunities and technological innovation, with a focus on AI products and maintaining high production capacity [6] Group 2: Financial Performance - Jerry Holdings reported a cash flow from operating activities of 2.594 billion, a year-on-year increase of 147.3% [1] - SuShi Testing expects a main business revenue of 1.920 billion, a decrease of 4.56%, and a net profit of 229.41 million, down 27% [3] - Aerospace Rainbow's drone export revenue is approximately 1.3 billion, with a gross margin of about 36% [4] - Guanghe Technology achieved an operating income of 3.734 billion, a year-on-year increase of 39.43%, and a net profit of 676 million, up 63.04% [6]

Core Viewpoint - The company reported a revenue of 725 million yuan for 2024, reflecting a year-on-year increase of 6.7%, and a net profit attributable to shareholders of 176 million yuan, up 7.7% year-on-year [1] Group 1: Financial Performance - The company's revenue for Q4 2024 was 174 million yuan, showing a year-on-year growth of 3.0%, while the net profit for the same period was 33 million yuan, an increase of 8.7% year-on-year [1] - The non-recurring net profit attributable to shareholders for 2024 was 165 million yuan, representing a year-on-year increase of 10.8% [1] - The gross profit margin for 2024 was 58.0%, a decrease of 1.11 percentage points year-on-year, with specific margins for automotive testing, electronic products testing, and testing equipment at 67.71%, 60.98%, and 39.10% respectively [3] Group 2: Business Segments - Automotive testing revenue reached 306 million yuan, growing 12.4% year-on-year, although the growth rate has slowed compared to previous years [2] - Revenue from electronic and electrical product testing was 171 million yuan, reflecting a steady growth of 9.1% year-on-year [2] - Revenue from testing equipment declined by 5.9% year-on-year to 154 million yuan, attributed to price competition in the manufacturing sector [2] - Daily consumer goods testing revenue increased by 22.2% year-on-year to 50 million yuan, while health and environmental testing revenue grew by 7.0% year-on-year to 45 million yuan [2] Group 3: Future Outlook - The company established a joint venture for robotics technology, aiming to create new growth avenues, with a focus on the development and sales of various types of robots [4] - Revenue projections for 2025-2027 are estimated at 849 million yuan, 971 million yuan, and 1.103 billion yuan, with corresponding year-on-year growth rates of 17.1%, 14.4%, and 13.6% [4] - The forecasted net profit attributable to shareholders for the same period is 208 million yuan, 248 million yuan, and 287 million yuan, with growth rates of 17.9%, 19.4%, and 15.9% respectively [4]

Core Viewpoint - The article emphasizes the ongoing efforts by regulatory bodies to stabilize and enhance the capital market, support technological innovation, and implement comprehensive reforms in the financial sector [2][3]. Group 1: Regulatory Developments - The China Securities Regulatory Commission (CSRC) is committed to consolidating the positive momentum in the capital market and will support the issuance and listing of quality unprofitable tech companies [2][3]. - A new round of capital market reforms will be fully initiated, focusing on deepening investment and financing reforms to achieve tangible results [3]. - The CSRC aims to enhance regulatory efficiency and strengthen the legal framework to combat severe violations effectively [3]. Group 2: Economic Indicators - Data from the State Taxation Administration indicates that from October 2024 to February 2025, the sales revenue growth rate of enterprises increased by 1.1 percentage points compared to Q3 2024, reflecting a recovering economy [4]. - Manufacturing sales revenue grew by 3.6% year-on-year during the same period, with high-tech industries seeing a 10.6% increase [5]. Group 3: Local Government Initiatives - The Ministry of Natural Resources and the Ministry of Finance have issued guidelines for the issuance and use of special bonds for land reserves, emphasizing strict project correspondence and financial balance [6]. - Shenzhen has launched a new policy to promote venture capital and private equity development, aiming for over 10,000 VC/PE funds by the end of 2026 [7]. Group 4: Market Movements and Company Announcements - The Social Security Fund has emerged as a significant shareholder in 12 companies, indicating a focus on firms with strong performance and high cash dividend ratios [8]. - Companies like Jinzi Tianzheng and Dawi Technology have clarified their business operations in response to market speculation, ensuring investors are informed about their actual business activities [10][12]. Group 5: Financial Performance Highlights - Baihua Pharmaceutical reported a net profit of 41.48 million yuan for 2024, a year-on-year increase of 219.75% [15]. - Jingfeng Mingyuan announced a revenue of 1.504 billion yuan for 2024, with a net loss of 33.05 million yuan, while planning to distribute dividends [16]. Group 6: Shareholder Actions - Huayi Brothers plans to transfer shares of Hero Mutual Entertainment for 336 million yuan, indicating strategic adjustments in their investment portfolio [17]. - Shaanxi Energy's major shareholder plans to increase their stake in the company by 250 million to 500 million yuan, reflecting confidence in the company's future [19].